Pramipexole 0.25mg Tablets

Pramipexole 0.25mg is an oral dopamine agonist used for Parkinson's disease symptoms and moderate-to-severe primary restless legs syndrome for pramipexole treatment. It stimulates dopamine receptors in the brain, helping improve movement symptoms in Parkinson's disease and reducing uncomfortable leg sensations and the urge to move in restless legs syndrome. A key safety issue is sudden sleep episodes during daily activities, sometimes without warning. Another important risk is impulse-control behavior, such as compulsive gambling, shopping, eating, or sexual urges. Restless legs syndrome can also worsen or start earlier in the day with long-term dopaminergic therapy, a pattern called augmentation.
Take Pramipexole 0.25mg exactly as prescribed. Dose changes are gradual and depend on indication, kidney function, symptom response, and side effects. Avoid driving if sleepy or dizzy.
Pramipexole stimulates dopamine receptors, helping compensate for dopamine signaling changes involved in Parkinson's disease and restless legs syndrome.
Possible effects include nausea, dizziness, sleepiness, insomnia, constipation, headache, swelling, abnormal dreams, low blood pressure on standing, hallucinations, and dyskinesia. Serious concerns include sudden sleep attacks, impulse-control behavior, severe confusion, psychosis, and withdrawal symptoms after abrupt stopping.
Review kidney function, daytime sleepiness, driving or machinery work, hallucinations, psychosis, low blood pressure, impulse-control history, pregnancy, breastfeeding, alcohol, sedatives, dopamine blockers, and restless-legs augmentation.
Parkinson's disease symptoms or moderate-to-severe primary restless legs syndrome when pramipexole is prescribed.
Can improve dopamine-related movement symptoms and reduce restless-leg discomfort when dosing is individualized and side effects are monitored.
Pramipexole 0.25mg is used for Parkinson's disease symptoms and moderate-to-severe primary restless legs syndrome when prescribed.
Gradual dose adjustment helps reduce dizziness, sleepiness, nausea, hallucinations, and blood-pressure effects.
Yes. Pramipexole can cause sudden sleep episodes, so driving and machinery use need caution.
New gambling, shopping, eating, sexual urges, or other compulsive behaviors should be reported quickly.
Yes. Symptoms that start earlier, spread, or intensify may indicate augmentation and need dose review.
No. Abrupt stopping can worsen symptoms or cause withdrawal effects, so changes should be supervised.
Pramipexole, Dopamine agonist, Parkinson disease medicine, Restless legs syndrome treatment, Sleep attack warning, Impulse control behavior, AR: Pramipexole أقراص, FR: Pramipexole comprimé, PT: Pramipexole comprimido, ES: Pramipexole tableta, RU: Pramipexole таблетки, ID: Pramipexole, VI: Pramipexole viên nén, MS: Pramipexole, TL: Pramipexole tableta, ZH-SG: Pramipexole 片剂
International B2B Enquiry
Send a structured B2B enquiry for Pramipexole 0.25mg Tablets under Neuro Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Pramipexole 0.25mg Tablets